How should we treat mesothelioma in 2003?

P. Astoul (Marseille, France)

Source: Annual Congress 2003 - PG15 - Pleural diseases
Session: PG15 - Pleural diseases
Session type: Postgraduate Course
Number: 93

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Astoul (Marseille, France). How should we treat mesothelioma in 2003?. Annual Congress 2003 - PG15 - Pleural diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Trends in mesothelioma diagnosis in Australia between 1993 and 2003
Source: Annual Congress 2005 - Old timers still around: fibres and inorganic dusts
Year: 2005


Malignant pleural mesothelioma: new treatments, new hopes?
Source: Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017
Year: 2017


Multimodal management of malignant pleural mesothelioma: where are we today?
Source: Eur Respir J 2014; 44: 754-764
Year: 2014



About 74 cases of pleural mesothelioma observed in the department between 2001 and 2011
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013

Immunotherapy for malignant pleural mesothelioma: ready for clinical practice?
Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies?
Year: 2016


Malignant pleural mesothelioma: new treatment modalities
Source: Annual Congress 2005 - Clinical year in review
Year: 2005

Time to diagnosis and time to therapy in patients with malignant pleural mesothelioma (MPM) compared to patients with lung cancer in Denmark 2007 to 2011. A quality assurance analysis
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012


Treating mesothelioma in 2021: what is the role of surgery and immunotherapy?
Source: Virtual Congress 2021 – Hot news from the pleura
Year: 2021


Mesothelioma: a hope in 2013?
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013


Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Source: Eur Respir Rev 2016; 25: 472-486
Year: 2016



Malignant mesothelioma (MM) in Metsovo, Greece from domestic use of tremolite asbestos; only one case since 2002
Source: Annual Congress 2010 - Mineral dusts and respiratory disease
Year: 2010


Late Breaking Abstract: Epidemiological tendencies in malignant mesotheliomas in Bulgaria during the 1990-2000 period
Source: Annual Congress 2010 - Indoor air and respiratory disease
Year: 2010

What is the best oncological management strategy for mesothelioma in 2018?
Source: International Congress 2018 – Malignant pleural effusions
Year: 2018


Surgery for mesothelioma: who are the long-term survivors?
Source: Breathe 2009; 6: 66
Year: 2009

Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
Source: Eur Respir Rev 2015; 24: 115-131
Year: 2015



IPC-related pleural infection vs. colonisation - to treat or not to treat?
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019